Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (61-70 of 635) with videos related to

Pageof 64
Sort By:
Postgraduate Medicine|May 14, 2010
A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetesRobert Frederich, John H Alexander, Fred T Fiedorek, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2020
Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 InfectionRoham T Zamanian, Charles V Pollack, Michael A Gentile, et al.
The Canadian Journal of Cardiology|April 28, 2006
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarctionJustin A Ezekowitz, Pierre Théroux, Weiching Chang, et al.
Journal of Thrombosis and Thrombolysis|June 22, 2016
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarctionSean van Diepen, Wendimagegn G Alemayehu, Yinggan Zheng, et al.
JACC. Cardiovascular Interventions|July 20, 2013
Prognostic significance of bleeding location and severity among patients with acute coronary syndromesJohn P Vavalle, Robert Clare, Karen Chiswell, et al.
American Heart Journal|January 25, 2008
Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapyDerek P Chew, Zhen Huang, Karen S Pieper, et al.
Circulation. Cardiovascular Quality and Outcomes|July 20, 2012
Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forwardZubin J Eapen, W H Wilson Tang, G Michael Felker, et al.
The Journal of Vascular Access|November 28, 2019
A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturationChristoph B Olivier, Vandana Sundaram, Glenn M Chertow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trialsStuart D Russell, Kimberly L Blackwell, Julia Lawrence, et al.
Diabetes Care|November 7, 2020
Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment StudyJames L Januzzi, Javed Butler, Naveed Sattar, et al.
Pageof 64

Showing results (61-70 of 635) with videos related to

Sort By:
Pageof 64
Postgraduate Medicine|May 14, 2010
A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetesRobert Frederich, John H Alexander, Fred T Fiedorek, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2020
Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 InfectionRoham T Zamanian, Charles V Pollack, Michael A Gentile, et al.
The Canadian Journal of Cardiology|April 28, 2006
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarctionJustin A Ezekowitz, Pierre Théroux, Weiching Chang, et al.
Journal of Thrombosis and Thrombolysis|June 22, 2016
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarctionSean van Diepen, Wendimagegn G Alemayehu, Yinggan Zheng, et al.
JACC. Cardiovascular Interventions|July 20, 2013
Prognostic significance of bleeding location and severity among patients with acute coronary syndromesJohn P Vavalle, Robert Clare, Karen Chiswell, et al.
American Heart Journal|January 25, 2008
Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapyDerek P Chew, Zhen Huang, Karen S Pieper, et al.
Circulation. Cardiovascular Quality and Outcomes|July 20, 2012
Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forwardZubin J Eapen, W H Wilson Tang, G Michael Felker, et al.
The Journal of Vascular Access|November 28, 2019
A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturationChristoph B Olivier, Vandana Sundaram, Glenn M Chertow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trialsStuart D Russell, Kimberly L Blackwell, Julia Lawrence, et al.
Diabetes Care|November 7, 2020
Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment StudyJames L Januzzi, Javed Butler, Naveed Sattar, et al.
Pageof 64